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Aims and objectives: To analyse the prevalence, risk factors and evolution over
time of polypharmacy and self-medication in the older people in Spain from 2006–
2014.
Background: Polypharmacy is a public health problem for older people worldwide
which causes different negative effects on their health, increasing health costs and
pharmaceutical spending. However, previous studies do not include nationally repre-
sentative samples and none of them provide updated data.
Design: Cross-sectional study with community-dwelling older adults (N = 26,277)
who participated in the National Health Survey in Spain in 2006 and 2011/2012
and the European Health Survey in Spain in 2009 and 2014.
Methods: Polypharmacy (defined as use of five or more medications in the last
2 weeks), excessive polypharmacy (defined as use of ten or more medications in the
last 2 weeks) and self-medication (defined as use of medications without a prescrip-
tion) were evaluated. A logistic regression was used for to know the association
between polypharmacy and self-medication with the sociodemographic
characteristic.
Results: The participants were 62% female and 38% male. The mean medication
consumption was 2.96 (SD  2.11). Prevalence of polypharmacy was present in
21.9%, prevalence of excessive polypharmacy was 0.6%, and prevalence of self-
medication was 10.7%. The most commonly used medications were for blood pres-
sure (51.6%), pain (42.8%) and cholesterol (28.2%). Polypharmacy is associated with
sex (females), age, being separated/divorced/widowed, lack of education, higher
body mass index, being bedridden during the last 2 weeks and self-medication.
Conclusions: The prevalence of polypharmacy and prevalence of self-medication
are considerable, and they increased significantly from 2006–2014.
Relevance to clinical practice: To deal with polypharmacy is a big challenge for
nurses. These data suggest to establish innovative clinical strategies in which the
health professionals and the patients are involved to improve the personal beha-
viour with medicines and to reduce the risks and costs of polypharmacy and
self-medication.
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1 | INTRODUCTION
The world’s population is ageing; it is estimated that between 2015–
2030, the number of people aged 60 and over will grow by 56%
worldwide. In Europe, older people (OP) over 60 years will increase
from 19.8% in 2015 to 23.1% in 2030 (United Nations, 2015). In
Spain, it is estimated that the population over 60 years of age will
constitute 33.5% of the total population by 2030 (United Nations,
2015). Age is associated with increases in chronic diseases, func-
tional limitations and morbidity, resulting in a greater use of health
services and increased consumption of drugs (Fried et al., 2014;
Lopes, Figueiredo, Costa, & Reis, 2016), which becomes a challenge
for the health system (Lutz, Miranda, & Bertoldi, 2017).
The use of multiple medications by a person (usually ≥5) is
defined as “polypharmacy” (Aguirre et al., 2017), although there is
currently no consensus on this definition in the literature (Maher,
Hanlon, & Hajjar, 2014). Polypharmacy has also been defined as the
use of more medications than is medically necessary. Within
polypharmacy, medications dispensed without prescription should be
included (Aguirre et al., 2017), that is self-medication, defined as the
selection and use of medications chosen by the patient for the treat-
ment of a disease and/or symptoms perceived by them (Arrais et al.,
2016). Therefore, self-medication is a potential cause of polyphar-
macy (Mortazavi et al., 2016).
Changes in age-related pharmacokinetics and pharmacodynamics
(due to decreases in body mass, body water content, renal function,
liver function and serum albumin levels), together with polyphar-
macy, produce negative health effects in the older people (Fried
et al., 2014; Gnjidic et al., 2012), such as adverse drug effects
(Cabello et al., 2016), falls (Lopez-Soto, Garcıa-Arcos, Fabbian, Man-
fredini, & Rodrıguez-Borrego, 2017), increased use of health services
(Gnjidic et al., 2012), increased health costs (Martin, Hartman, Ben-
son, & Catlin, 2016) and use of potentially inappropriate medicines
(PIMs) (Urfer, Elzi, Dell-Kuster, & Bassetti, 2016). To identify the use
of PIMs, extrinsic criteria, such as Start/Stop (Screening Tool to Alert
doctors to the Right Treatment/Screening Tool of Older Persons’ Pre-
scriptions) (O’mahony et al., 2015) and Beers criteria, updated in
2012 (Campanelli, 2012), are used.
2 | BACKGROUND
The use of medication in OP is a public health problem (Kim, Shin,
Kim, & Park, 2014) because the older people consume approximately
one-third of all prescribed drugs (Eiras et al., 2016). The prevalence
of polypharmacy varies according to the scope and country of study.
In Spain, previous studies have reported that OP generate three
times as much healthcare demand as the average population and
generate 75% of pharmaceutical expenditures (Nu~nez et al., 2014).
However, the studies conducted in Spain on polypharmacy are
scarce, and the prevalence of OP with polypharmacy in the commu-
nity ranges from 20.6%–45% (Blanco-Reina, Ariza-Zafra, Oca~na-Riola,
Leon-Ortız, & Bellido-Estevez, 2015; Frutos, Martın, & Galindo,
2011; Garrido-Garrido et al., 2011; Martin-Perez et al., 2017), being
higher in the hospital setting (92.4%) according to Agustı, Formiga,
and San-Jose (2017). In addition, most of the existing studies do not
include nationally representative samples, and none of them provide
updated data for the past 5 years.
On the other hand, referring to Spain, community nurses are the
health professionals that have most direct contact with OP (Dios-
Guerra, Carmona-Torres, Ruız-Gandara, Mu~noz-Alonso, & Rodrıguez-
Borrego, 2015) and who have an important task in the area of
educational health. Community nurses must help OP to deal with
medications, for preventing the negative consequences of self-medi-
cation and polypharmacy (Dios-Guerra & Perula de Torres, 2012).
Therefore, the objective of this study was to analyse the preva-
lence, associated factors and evolution over time of polypharmacy
and self-medication in OP from 2006–2014 in Spain.
3 | METHODS
3.1 | Design and study population
This was a cross-sectional descriptive study. The sources of infor-
mation were the National Health Survey in Spain (NHSS) 2006
(Ministerio de Sanidad Servicios Sociales e Igualdad 2006) and
What does this paper contribute to the wider
global clinical community?
• It is the first study with a large sample that analyses the
prevalence, associated factors and temporal trends of
polypharmacy and self-medication among Spanish older
people in the periods 2006–2014.
• Our study shows the associated factors with polyphar-
macy and self-medication in Spanish older people. In
addition, the prevalence of polypharmacy and prevalence
of self-medication are increasing in older people from
2006–2014 in Spain.
• In spite of there are no consensus in the use of medica-
ments to treat cholesterol, there were an increase in their
consumption by Spanish older people.
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2011/2012 (Ministerio de Sanidad Servicios Sociales e Igualdad
2013) and the European Health Survey in Spain (EHSS) 2009 (Min-
isterio de Sanidad Servicios Sociales e Igualdad 2010) and 2014
(Ministerio de Sanidad Servicios Sociales e Igualdad 2015), per-
formed by the National Institute of Statistic (NIS) and the Ministry
of Health, Social Services and Equality (MHSSE). These surveys are
conducted in noninstitutionalised individuals through personalised
interviews. They use a three-stage sampling design with stratifica-
tion in the first stage: the first-stage units are the census tracts,
the second-stage units are the family dwellings, and the third-stage
units are the surveyable people present in the home. The first-
stage units are grouped into strata according to the size of the
municipality to which the sections belong. Each participant is
assigned a weighting coefficient to ensure the representativeness
of the sample. Microdata are available and anonymous; therefore,
no special permits were required for their use. The study popula-
tion was restricted to people aged ≥65 years, living in Spain. The
total number of records used was 26,277: 7,835 in 2006; 6,026 in
2009; 5,896 in 2011/2012; and 6,520 in 2014.
3.2 | Variables
The variables included in each registry were age (this variable was
categorised in groups of age), sex, nationality, domestic partnership,
marital status, level of education, perceived contributory pension,
bedridden during the last 2 weeks, body mass index (BMI), social
class, consumption of medications in the last 2 weeks prescribed by
a physician, consumption of medications in the last 2 weeks not pre-
scribed by a physician and medications consumed (for cold/flu/
throat/bronchi, pain, fever, vitamins and minerals, laxatives, antibi-
otics, tranquillisers/relaxants/sleeping pills, allergy, diarrhoea,
rheumatism, heart, blood pressure, stomach and/or digestive disor-
ders, antidepressants/stimulants, cholesterol, diabetes, thyroid,
homoeopathic, naturopathic and other medications).
Social class was established according to the categories proposed
by the Spanish Society of Epidemiology (Domingo-Salvany et al.,
2013).
The polypharmacy variable was calculated from an identical
question in all questionnaires: “I will now read you a list of medica-
tion types, please tell me which one or which of them have you con-
sumed in the last two weeks, and which ones were prescribed by a
physician?” based on groups of medications used to treat diseases/
symptoms, including colds/flu/throat/bronchi, pain, fever, laxatives
and antibiotics. Participants were classified as polypharmacy (yes/no)
if they answered yes to five or more questions about the consump-
tion of different medication groups in the last 2 weeks. Although
there is no consensus yet on the number of medication that must be
consumed to be considered polypharmacy, this figure (five medica-
tions) has been used in recent studies conducted in different coun-
tries (Eiras et al., 2016; Gnjidic et al., 2012; Lopes et al., 2016; Urfer
et al., 2016).
The self-medication variable was calculated based on whether
the respondent had answered yes to the question “During the
last two weeks, have you taken any medications, including
herbal medicines or vitamins that were not prescribed by a
physician?”
3.3 | Process
The research team contacted NIS to determine access to microdata.
The different microdata files (Ministerio de Sanidad Servicios
Sociales e Igualdad 2006, 2010, 2013, 2015) were downloaded, and
a single database was created. To make a comparison of the data in
each of the years of the survey, they were recorded according to
the established methodology, expressed in the section variables.
Finally, we performed a statistical analysis and an interannual
comparison.
3.4 | Statistical analysis
A descriptive analysis was performed by calculating counts (n) and
proportions (%) for qualitative variables and by calculating means
and standard deviations (SD) for quantitative variables. A comparison
of categorical variables was performed using chi-square tests for
contingency tables. In addition, a logistic regression was performed
to identify the variables associated with polypharmacy and self-med-
ication. Odds ratios (OR) were calculated with their respective 95%
confidence intervals (95% CI).
All hypothesis comparisons were bilateral, and in all statistical
tests, “significant” values were those whose confidence levels were
95% (p < .05). The statistical analysis was performed with IBM SPSS
Statistics version 22 (IBM Corp, Armonk, NY, USA), licensed to the
University of Castilla La Mancha.
4 | RESULTS
The total sample was 26,277 records of OP, including 62% women
and 38% men, with a mean age of 75.59 years (SD  7.19). A total
of 98% of the OP were of Spanish nationality, and 48.4% lived with
partners. The most frequent sociodemographic characteristics of the
OP were that they were married (49.2%), had primary or secondary
school education (44.6%), had a contributory pension (95.1%), had
not been bedridden during the last 2 weeks, belonged to social class
V (26.5%) and were overweight (38.6%). Table 1 shows the sociode-
mographic characteristics of the participants according to the year of
the interview.
The mean medication consumption in participants was 2.96
(SD2.11) (Figure 1). Polypharmacy (≥5 medications consumed in
the last 2 weeks) was present in 21.9% of the participants, with an
average consumption of 6.11 (SD  1.36). Hyperpolypharmacy or
excessive polypharmacy (≥10 medications consumed in the last
2 weeks) was present in 0.6% of participants. The medications most
consumed in the sample were medications for blood pressure
(51.6%), pain (42.8%) and cholesterol (28.2%); tranquillisers, relaxants
and sleeping pills (24.4%); and medications for stomach and/or
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digestive disorders (24.2%) and for the heart (20.3%). Polypharmacy
increased in prevalence according to the years of study (p < .001),
showing a higher prevalence in 2014, as did self-medication
(p < .001). The prevalence rates of the different groups of medica-
tions consumed and their evolution over time are shown in Figures 2
and 3.
TABLE 1 Sociodemographic
characteristics of Spanish people over




n = 7,835 (%)
2009
n = 6,026 (%)
2011/2012
n = 5,896 (%)
2014
n = 6,520 (%)
Sex
Male 2,813 (35.9) 2,330 (38.7) 2,223 (37.7) 2,624 (40.2)
Female 5,022 (64.1) 3,696 (61.3) 3,673 (62.3) 3,896 (59.8)
Age group (years)
65–74 3,931 (50.2) 2,849 (47.3) 2,731 (46.3) 3,125 (47.9)
75–84 3,157 (40.3) 2,426 (40.3) 2,350 (39.9) 2,423 (37.2)
≥85 747 (9.5) 751 (2.5) 815 (13.8) 972 (14.9)
Domestic partnership
Yes Not registered 2,925 (48.5) Not registered 3,145 (48.3)
No 3,098 (51.4) 3,365 (51.6)
Marital status
Single Not registered 536 (8.9) 489 (8.3) 554 (8.5)
Married 2,926 (48.6) 2,912 (49.4) 3,234 (49.6)
Widowed 2,396 (39.8) 2,310 (39.2) 2,502 (38.4)
Separated 84 (1.4) 84 (1.4) 105 (1.6)
Divorced 79 (1.3) 96 (1.6) 119 (1.8)
Nationality
Spanish Not registered 5,943 (98.6) 5,827 (98.8) 6,442 (98.8)
Foreigner 83 (1.4) 69 (1.2) 78 (1.2)
Level of education
Without studies Not registered 2,805 (46.6) Not registered 2,230 (34.2)
Primary 2,376 (39.5) 3,209 (49.2)
Secondary or PT 478 (7.9) 564 (8.7)
University 355 (5.9) 517 (7.9)
Bedridden
Yes Not registered Not registered 418 (7.1) 531 (8.2)
No 5,478 (92.9) 5,987 (91.8)
Social class
Class I 313 (4) Not registered 417 (7.1) 482 (7.4)
Class II 416 (5.3) 309 (5.2) 416 (6.4)
Class III 1,899 (24.2) 869 (14.7) 1,030 (15.8)
Class IV 1,644 (21) 821 (13.9) 1,053 (16.2)
Class V 943 (12) 2,106 (35.7) 2,312 (35.5)
Class VI 1,468 (18.7) 991 (16.8) 976 (15)
No answer 1,152 (14.7) 383 (6.5) 251 (3.8)
BMIa
Insufficient Not registered 56 (0.9) 47 (0.8) 69 (1.1)
Normal weight 1,490 (24.7) 1,370 (23.2) 1,829 (28.1)
Overweight 2,361 (39.2) 2,116 (35.9) 2,644 (40.6)
Obesity 1,210 (20.1) 1,158 (19.6) 1,369 (21)
No answer 909 (15.1) 1,205 (20.4) 609 (9.3)
BMI, body mass index; PT, professional training.
aThe valour considered for calculating BMI were insufficient <18.5; normal weight 18.5–25; over-
weight 25–30; and obesity >30.
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Regarding self-medication (Figure 2), only 7.79% of the OP in
2009 were self-medicated, a proportion that increased to 13.3% in
2014 (p < .001). This variable was not included in the NHSS 2006
and 2011/2012.
Table 2 shows the sociodemographic characteristics of the par-
ticipants by polypharmacy groups and self-medication groups.
In the logistic regression analysis (Table 3), we observed that
polypharmacy was associated with sex, women have 1.82 times
more likely to have polypharmacy than men (95% CI, 1.56–2.12)
(p < .001); age: people aged 75–84 years have 1.44 times more
likely to have polypharmacy than those aged 65–74 years (95% CI,
1.24–1.67) (p < .001); marital status: separated/divorced/widowed
people have 1.38 times more likely to have polypharmacy than single
people (95% CI, 1.06–1.79) (p = .015); level of education: OP with-
out studies have 2.12 times more likely to have polypharmacy than
OP with university education (95% CI, 1.59–2.81) (p < .001); BMI:
overweight or obese people have 1.65 times more likely to have
polypharmacy than those with normal weight (95% CI, 1.41–1.92)
(p < .001); bed rest: people who had been bedridden during the last
week have 3.75 times more likely to have polypharmacy than those
not bedridden (95% CI, 3.01–4.68) (p < .001); and self-medication:
self-medicated OP have 1.45 times more likely to have polyphar-
macy than non-self-medicated OP (95% CI, 1.2–1.75) (p < .001).
The logistic regression analysis (Table 4) shows that self-medica-
tion is associated with female sex (OR, 1.49; 95% CI, 1.25–1.77)
(p < .001); education level: OP with university education have 1.92
times more likely to self-medicate than those without studies (95%
CI, 1.43–2.58) (p < .001); and BMI: obese or overweight OP have
1.27 times more likely to self-medicate than those of normal weight
(95% CI, 1.05–1.54) (p = .013).
5 | DISCUSSION
Polypharmacy is a public health problem that is increasing with the
passage of time due to the increase in life expectancy and the
characteristics derived from ageing. Our data broaden the informa-
tion of previous studies conducted in Spain (Blanco-Reina et al.,
2015; Frutos et al., 2011; Garrido-Garrido et al., 2011; Martin-Perez
et al., 2017). Like the previous literature (Charlesworth, Smit, Lee,
Alramadhan, & Odden, 2015; Martin-Perez et al., 2017; Nishtala &
Salahudeen, 2015), our data show that there has been an increase in
the number of medications consumed by the older population in
recent years. This increase in medication use is possibly the result of
a combination of factors, such as increased chronicity and morbidity,
irrational drug use and increased availability of drugs (Blanco-Reina
et al., 2015; Fried et al., 2014; Lopes et al., 2016; Wang et al.,
2015). Although increasing medication use may mean greater access
to treatments and better approaches to disease, polypharmacy is
becoming a critical problem, as it causes a multitude of problems for
the older person (even if prescribed), such as increased adverse drug
reactions, side effects, hospitalisations, falls and use of PIMs (Char-
lesworth et al., 2015; Lutz et al., 2017; Maher et al., 2014), which
are associated with an increased risk of mortality (Gomez et al.,
2015).
In our study, the most commonly used medication was for blood
pressure, as was seen in another study in China (Wang et al., 2015).
This observation may be due to the fact that hypertension is one of
the most common pathologies in Spain, with a prevalence of 90% in
those older than 75 years (Menendez et al., 2016). The second most
commonly used medication was analgesics, which coincides with
another study in Ethiopia, where pain medications were the most
consumed (Eticha & Mesfin, 2014). This data may be due to the
increase in chronic pain with age and because many of these drugs
can be bought without prescription (Baldoni et al., 2014; Eticha &
Mesfin, 2014). It is surprising that the consumption of cholesterol
medications increased from 2006–2014, as recent studies have
reported that there is a lack of evidence for the use of drugs to
reduce cholesterol levels because, despite the increase in consump-
tion, there has not been a significant decrease in cholesterol levels.
Therefore, medical and scientific associations do not recommend the
routine prescription of cholesterol-lowering medication in adults over
F IGURE 1 Prevalence of the number of
consumed medications by Spanish people
over 65 years in the period 2006–2014
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70 years old (Charlesworth et al., 2015). Also surprising is the
increased consumption of tranquillisers, relaxants and sleeping pills
from 2006–2014, although studies have shown that most benzodi-
azepines are PIMs and are not recommended as first-line drugs to
treat insomnia due to the negative effects they cause, such as cogni-
tive impairment or falls (Pek et al., 2017).
In Spain, the incidence rates of polypharmacy (≥5 medications)
and hyperpolypharmacy (or excessive polypharmacy, ≥10 medica-
tions) in OP living at home (not in a hospital setting) are lower
than in other countries using nationally representative samples,
such as the United States (Charlesworth et al., 2015) or New Zeal-
and (Nishtala & Salahudeen, 2015). The existence of studies that
consider polypharmacy to be the consumption of ≥4 medications
and the lack of consensus on the definition of polypharmacy limit
the comparison of our results with other studies. Likewise, data on
self-medication are also inferior to other studies conducted in other
countries, such as Portugal (Baldoni et al., 2014) or Colombia
(Machado-Alba et al., 2014), because in Spain, there is less dispen-
sation of medications without prescription compared with other
countries.
Among the risk factors associated with polypharmacy in our
study, it is observed, as in other studies, that it is associated with
being a woman (Martin-Perez et al., 2017; Nishtala & Salahudeen,
2015; Santos et al., 2013), being older (Charlesworth et al., 2015;
Kim et al., 2014), being separated/divorced/widowed (Santos et al.,
2013), having a lower education level (Martınez-Arroyo, Gomez-Gar-
cia, & Sauceda-Martınez, 2014) and self-medicating (Eticha & Mesfin,
2014; Lutz et al., 2017; Mortazavi et al., 2016). However, there are
F IGURE 2 Prevalence of the different groups of consumed medications by Spanish people over 65 years in the period 2006–2014
F IGURE 3 Prevalence of polypharmacy
and self-medication in Spanish people over
65 years in the period 2006–2014
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n = 5,753 (%)
No
n = 20,524 (%)
Yes
n = 7,399 (%)
No
n = 18,878 (%)
Sex
Male 1,520 (26.4) 8,470 (41.3) <.001 2,566 (34.7) 7,424 (39.3) <.001
Female 4,233 (73.6) 12,054 (58.7) 4,833 (65.3) 11,454 (60.7)
Age group (years)
65–74 2,302 (40) 10,334 (50.4) <.001 3,508 (47.4) 9,128 (48.4) .093
75–84 2,591 (45) 7,765 (37.8) 2,992 (40.4) 7,364 (39)
≥85 860 (15) 2,425 (11.8) 899 (12.2) 2,386 (12.6)
Domestic partnership
Yes 1,087 (41.9) 4,983 (50.1) <.001 2,920 (48.4) 3,150 (48.5) .061
No 1,508 (58.1) 4,955(49.9) 3,116 (51.6) 3,347 (51.5)
Marital status
Single 251 (6.1) 1,328 (9.3) <.001 530 (8.2) 1,049 (8.8) .107
Married 1,756 (42.7) 7,316 (51.1) 3,159 (48.3) 5,913 (49.7)
Widowed 1,987 (48.3) 5,221 (36.4) 2,651 (40.5) 4,557 (38.3)
Separated 57 (1.4) 216 (1.5) 93 (1.4) 180 (1.6)
Divorced 61 (1.5) 233 (1.6) 102 (1.6) 192 (1.6)
Nationality
Spanish 4,088 (99.4) 14,124 (98.6) <.001 6,450 (98.6) 11,762 (98.8) .085
Foreigner 26 (0.6) 204 (1.4) 92 (1.4) 138 (1.2)
Level of education
Without studies 1,280 (49.4) 3,755 (37.8) <.001 2,727 (45.2) 2,308 (35.5) <.001
Primary 1,030 (39.7) 4,555 (45.8) 2,445 (40.6) 3,140 (48.3)
Secondary or PT 164 (6.3) 878 (8.8) 473 (7.8) 569 (8.7)
University 119 (4.6) 753 (7.6) 383 (6.4) 489 (7.5)
Bedridden
Yes 553 (16.8) 396 (4.4) <.001 85 (7.3) 864 (7.7) .923
No 2,741 (83.2) 8,724 (95.6) 1,086 (92.7) 10,379 (92.3)
Social class
Class I 218 (4.5) 994 (6.5) <.001 143 (7.5) 1,059 (5.8) <.001
Class II 224 (4.5) 917 (6) 140 (6.9) 1,001 (5.5)
Class III 834 (16.9) 2,964 (19.3) 414 (20.4) 3,384 (18.6)
Class IV 829 (16.8) 2,689 (17.6) 387 (19.1) 3,131 (17.2)
Class V 1,406 (28.5) 3,955 (25.8) 435 (21.4) 4,926 (27)
Class VI 988 (20) 2,447 (16) 319 (15.7) 3,116 (17.1)
No answer 434 (8.8) 1,352 (8.8) 180 (8.9) 1,606 (8.8)
BMIa
Insufficient 44 (1.1) 128 (0.8) <.001 66 (1) 106 (0.9) .332
Normal weight 782 (19) 3,907 (27.3) 1,611 (24.6) 3,078 (25.9)
Overweight 1,493 (36.3) 5,628 (39.3) 2,563 (39.2) 4,558 (38.3)
Obesity 1,132 (27.5) 2,605 (18.2) 1,345 (20.6) 2,392 (20.1)
No answer 663 (16.1) 2,060 (14.4) 957 (14.6) 1,766 (14.8)
BMI, body mass index; PT, professional training.
aThe valour considered for calculating BMI were insufficient <18.5; normal weight 18.5–25; overweight 25–30; and obesity >30.
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no known previous studies that have linked polypharmacy with
higher BMI and bed rest. This may be because overweight/obesity is
a risk factor for many diseases and therefore requires a greater num-
ber of drugs for treatment. Being bedridden during the last 2 weeks
may suggest that the person has been ill and thus the reason for
self-medication.
Among the factors associated with self-medication are female
sex and higher education level, as in previous studies (Baldoni et al.,
2014; Machado-Alba et al., 2014). In addition, in our study, self-
medication was associated with a higher BMI, that it would be possi-
ble due to the association between obesity and other diseases,
which require more medications.
5.1 | Limitations
Among the limitations of our study, whose sources have been the
records of the NHSS and EHSS, which are cross-sectional studies,
we were not able to determine the causal direction between
polypharmacy and the related variables. In addition, NHSS and EHSS
did not collect variables that may influence polypharmacy, such as
type of self-administered medication, previous hospital admissions,
PIMs, previous chronic diseases and health status. It is advisable to
include these variables in future studies. However, the current study
has great strength because the data were obtained from national
representative surveys with a large number of participants and rep-
resent a step towards gaining knowledge of this problem in today’s
society.
6 | CONCLUSION
In conclusion, the prevalence of polypharmacy is considerable and
increased significantly from 2006–2014. Polypharmacy is associated
with sex (female), being older, being separated/divorced/widowed,
being without studies, having a higher BMI, being bedridden during
the last 2 weeks and self-medicating. In addition, there were
increases in the consumption of medicaments to treat cholesterol
and tranquillisers/relaxants/sleeping pills, when there is no consen-
sus in their use because there is evidence that they do not have suf-
ficient therapeutic efficacy, in the case of statins, and that they
cannot overcome the side effects of the therapeutic effect, in the
case of the benzodiazepines, which is why medical and scientific
associations have recommended not to use them. However, self-
medication in Spain has a lower prevalence than in other countries,
although the gradual increase in time is cause for concern, and it is
associated with the female sex, lack of university education and
higher BMI. Therefore, it is considered necessary to raise awareness
among health professionals, specially nurses, and to implement pro-
grammes to mitigate the problem.
TABLE 3 Logistic regression model for the association between
sociodemographic characteristics and polypharmacy in Spanish
people over 65 years (2006–2014)
OR (95% CI) p-Value
Sex
Male Reference
Female 1.82 (1.56–2.12) <.001
Age group (years)
65–74 Reference
75–84 1.44 (1.24–1.67) <.001
≥85 1.4 (1.14–1.71) .001
Marital status
Single Reference
Married 1.3 (1–1.69) .05
Separated/divorced/widowed 1.38 (1.06–1.79) .015
Level of education
Without studies 2.12 (1.59–2.81) <.001
Primary 1.32 (1–1.74) .048
Secondary or PT 1.06 (0.75–1.52) .731
University Reference
BMI
Normal weight (18.5–25) Reference
Insufficient (<18.5) 1.7 (0.9–3.2) .103
Overweight or Obesity (≥25) 1.65 (1.41–1.92) <.001
Bedridden
No Reference
Yes 3.75 (3.01–4.68) <.001
Self-medication
No Reference
Yes 1.45 (1.2–1.75) <.001
BMI, body mass index; CI, confidence interval; OR, odds ratio; PT, pro-
fessional training.
TABLE 4 Logistic regression model for the association between
Sociodemographic Characteristics with self-medication in Spanish
people over 65 years (2006–2014)
OR (95% CI) p-Value
Sex
Male Reference
Female 1.49 (1.25–1.77) <.001
Level of education
Without studies Reference
Primary 1.22 (1–1.48) .052
Secondary or PT 1.42 (1.04–1.93) .026
University 1.92 (1.43–2.58) <.001
BMI
Normal weight (18.5–25) Reference
Insufficient (<18.5) 1.09 (0.48–2.46) .84
Overweight or Obesity (≥25) 1.27 (1.05–1.54) .013
BMI, body mass index; CI, confidence interval; OR, odds ratio; PT,
professional training.
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7 | RELEVANCE TO CLINICAL PRACTICE
Health professionals, in particular nursing, should be aware of this glo-
bal public health problem and should develop strategies to prevent it.
It can be possible to prevent the fatal consequences of polypharmacy
such as event adverse, falls or hospital admissions, through the knowl-
edge of the risk factors for polypharmacy, especially in noninstitution-
alised OP. In Spain, community nurses perform the highest number of
home visits (Dios-Guerra et al., 2015), so they have an important role
for preventing polypharmacy and self-medication, because they pro-
vide support with the use of medications (Westerbotn, Fahlstr€om,
Fastbom, Ag€uero-Torres, & Hilleras, 2008). The nurses have the
opportunity to assist in minimising the use of medications and self-
medications and have also the opportunity to lead initiatives aiming
to educate interdisciplinary team members and patients on improved
medication management practices (Kim & Parish, 2017).
It will be necessary to develop protocols to be implemented in pri-
mary care physician’s offices to reduce this problem, which can have
fatal consequences for the older person (Lutz et al., 2017). Although
Spain has established the improvement of care for patients with
polypharmacy as one of the priorities of health services and has initi-
ated specific programmes such as that performed in the region of Gali-
cia (Reboredo-Garcıa, Mateo, & Casal-Llorente, 2014), the results
show that the number of people with polypharmacy continues to
grow. For this reason, it is considered necessary to establish innovative
clinical strategies in which the nurse, the physician and the patient are
involved to combat polypharmacy to reduce the risks and costs of
medicines and to develop protocols for action (Charlesworth et al.,
2015). In addition, it appears necessary to include specific programmes
on this problem in the university studies of health professions as nurs-
ing degree to raise the awareness of future professionals and help to
reduce the problem. Increased consumption rates of cholesterol medi-
cations and tranquillisers/relaxants/sleeping pills justify further studies
exploring the causes and consequences of this usage, especially when
the literature does not recommend the use of statins and benzodi-
azepines due to lack of scientific evidence of their efficacy. Continu-
ous reassessments of the medication regime and current clinical status
of OP by physicians and nurses are required to avoid polypharmacy.
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